I just noticed that Dan Weiss, an Investment Director at Vestopia just wrote a piece countering Greenberg's comments. Its available at www.vestopia.com/danw. I believe you have to subscribe but its free.
Hanesbrands shares slide ~6% after Greenberg Meritz takes cautious stance According to a report late yesterday from Herb Greenberg's new research firm, Greenberg Meritz Research & Analytics or GMRA, investors may want to take a second look at Hanesbrands (HBI) before investing. The report looks at Hanesbrands "uninspiring" sales growth, quality of earnings as well as the headwinds the company is facing. GMRA's take is despite being spun off from Sarah Lee (SLE) less than two years ago, Hanesbrands' is still in the midst of a turnaround, its balance sheet and operating cash flow are deteriorating faster than normal and the company faces headwinds from a struggling economy, rising costs and intensifying competition.